Skip to content

Diaphragm Ultrasound and Rapid Shallow Breathing Index for Predicting Extubation Success

The Value of Combining Diaphragm Thickening Fraction and Rapid Shallow Breathing Index in Predicting Extubation Success in Intensive Care Unit Patients: A Prospective Observational Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07897617
Enrollment
80
Registered
2026-10-27
Start date
2026-11-01
Completion date
2028-05-01
Last updated
2026-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator Weaning, Respiratory Insufficiency

Keywords

Diaphragm Ultrasonography, Diaphragm Thickening Fraction, Diaphragm Excursion, Rapid Shallow Breathing Index, Extubation, Spontaneous Breathing Trial, Intensive Care Unit

Brief summary

The purpose of this study is to find out whether diaphragm ultrasound measurements, alone or combined with the rapid shallow breathing index (RSBI), can better predict successful removal of the breathing tube in adult intensive care unit patients on mechanical ventilation. Diaphragm thickening fraction and diaphragm excursion are measured with bedside ultrasound during the spontaneous breathing trial. Patients are followed after extubation to determine whether they need to be reintubated. The study does not change patient treatment; all measurements are non-invasive.

Detailed description

Weaning from mechanical ventilation is a critical phase of intensive care. Premature extubation increases the risk of reintubation, whereas delayed extubation increases ventilator-associated complications. The rapid shallow breathing index (RSBI) is widely used but has limited accuracy on its own. Diaphragm ultrasound, including diaphragm thickening fraction (DTF), has emerged as a reliable method for assessing diaphragm function. This prospective, observational, single-center study is conducted in the Reanimation Intensive Care Unit of Inonu University Turgut Ozal Medical Center, Malatya, Turkey. Adult patients who have received invasive mechanical ventilation for at least 48 hours and are scheduled for a spontaneous breathing trial (SBT) are enrolled after informed consent is obtained from a legally authorized representative. RSBI is calculated before the SBT. Right hemidiaphragm ultrasound is performed by the same investigator in all patients, who is blinded to the RSBI value and the extubation decision. DTF is measured at the beginning and at the end of the SBT, and the change in DTF between the two measurements is calculated. Diaphragm excursion is also recorded. The primary indication for mechanical ventilation is recorded using a predefined hierarchy. The primary outcome is extubation success, defined as the absence of reintubation or of respiratory failure not manageable with non-invasive ventilation or high-flow oxygen therapy within 48 hours after extubation. The diagnostic performance of DTF, diaphragm excursion, and RSBI, alone and in combination will be compared using receiver operating characteristic curve analysis with the combined DTF+RSBI model derived from logistic regression. The planned sample size is 80 patients.

Interventions

Right hemidiaphragm ultrasound measuring diaphragm thickening fraction at the beginning and end of the spontaneous breathing trial, the change between the two, and diaphragm excursion. Performed by a single investigator blinded to RSBI and the extubation decision.

Ratio of respiratory frequency to tidal volume (breaths/min/L) calculated before the spontaneous breathing trial.

Sponsors

Inonu University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Invasive mechanical ventilation via an orotracheal or nasotracheal tube for at least 48 hours * Planned spontaneous breathing trial * Meeting weaning criteria with a clinical decision for extubation * Informed consent obtained from a legally authorized representative

Exclusion criteria

* Diaphragm paralysis * Neuromuscular disease * High cervical spinal cord injury * Pregnancy * Inadequate ultrasound image quality * Tracheostomy * Severe obesity (BMI \> 35-40 kg/m2) * Advanced COPD or chronic respiratory failure * History of phrenic nerve injury (e.g., after cardiac surgery) * Neuromuscular blocking agent administration within the previous 24 hours * Inability to cooperate with the SBT due to severe agitation or delirium * Palliative/terminal care or life expectancy of less than 24 hours

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Performance of Combined DTF and RSBI for Predicting Extubation Success48 hours after extubationArea under the receiver operating characteristic curve (AUC) of the combined diaphragm thickening fraction and RSBI model compared with RSBI alone for predicting extubation success, defined as no reintubation and no respiratory failure unmanageable with non-invasive ventilation or high-flow oxygen therapy.

Secondary

MeasureTime frameDescription
Diaphragm Thickening FractionAt the beginning and at the end of the spontaneous breathing trialRight hemidiaphragm thickening fraction measured by ultrasonography, calculated as (end-inspiratory thickness minus end-expiratory thickness) divided by end-expiratory thickness, expressed as a percentage.
Change in Diaphragm Thickening Fraction During the Spontaneous Breathing TrialFrom the beginning to the end of the spontaneous breathing trialDifference between diaphragm thickening fraction measured at the end and at the beginning of the spontaneous breathing trial, in percentage points.
Diaphragm ExcursionAt the end of the spontaneous breathing trialRight hemidiaphragm excursion measured by M-mode ultrasonography, in centimeters.
Rapid Shallow Breathing IndexBefore the spontaneous breathing trialRatio of respiratory frequency to tidal volume, in breaths/min/L.
Hospital MortalityFrom extubation up to 28 daysNumber of participants who died from any cause during the hospital stay.
ICU Length of StayFrom ICU admission to ICU discharge, assessed up to 28 daysLength of intensive care unit stay, in days.
Hospital Length of StayFrom hospital admission to hospital discharge, assessed up to 28 daysTotal length of hospital stay, in days.
Reintubation Within 7 Days7 days after extubationProportion of patients requiring reintubation within 7 days after extubation.
ICU MortalityFrom extubation up to 28 daysNumber of participants who died from any cause during the intensive care unit stay.

Contacts

CONTACTGöksel Aydoğan, MD
drgoksel5533@gmail.com+905342428048
PRINCIPAL_INVESTIGATORAyşe Belin Özer, MD, Prof.

Intensive Care Unit, Inonu University turgut Ozal Medical Center,Malatya, Türkiye

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 28, 2026